Т. И. Романцова

613 total citations
39 papers, 134 citations indexed

About

Т. И. Романцова is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Т. И. Романцова has authored 39 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Т. И. Романцова's work include Cardiovascular Disease and Adiposity (6 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pharmacology and Obesity Treatment (5 papers). Т. И. Романцова is often cited by papers focused on Cardiovascular Disease and Adiposity (6 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pharmacology and Obesity Treatment (5 papers). Т. И. Романцова collaborates with scholars based in Russia, United States and Croatia. Т. И. Романцова's co-authors include И. И. Дедов, А. Ф. Ванин, В. А. Сереженков, Marina V. Shestakova, М Г Полуэктов, M. М. Tanashyan, В. В. Фадеев, М. В. Кротенкова, Marina Kalashnikova and Ametov As and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Mellitus and BIOPHYSICS.

In The Last Decade

Т. И. Романцова

33 papers receiving 116 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Т. И. Романцова Russia 8 44 40 34 27 24 39 134
Lorraine Albon United Kingdom 5 111 2.5× 37 0.9× 29 0.9× 32 1.2× 27 1.1× 10 182
François Schmitt France 6 32 0.7× 43 1.1× 36 1.1× 16 0.6× 23 1.0× 12 209
Н. И. Волкова Russia 7 35 0.8× 80 2.0× 37 1.1× 25 0.9× 10 0.4× 66 169
Alina Kerimkulova Kyrgyzstan 5 32 0.7× 28 0.7× 17 0.5× 24 0.9× 5 0.2× 17 90
Hermina Jakupović Finland 6 64 1.5× 59 1.5× 19 0.6× 23 0.9× 9 0.4× 7 204
Giorgia Querci Italy 8 110 2.5× 124 3.1× 28 0.8× 27 1.0× 9 0.4× 9 305
Olga Lunegova Kyrgyzstan 4 30 0.7× 29 0.7× 22 0.6× 23 0.9× 5 0.2× 23 93
Tomas Symersky Netherlands 8 60 1.4× 29 0.7× 63 1.9× 36 1.3× 5 0.2× 11 316
Zhaoxia Liang China 11 37 0.8× 20 0.5× 18 0.5× 42 1.6× 94 3.9× 34 272
Naeimeh Atabaki‐Pasdar United States 7 42 1.0× 96 2.4× 33 1.0× 25 0.9× 6 0.3× 12 180

Countries citing papers authored by Т. И. Романцова

Since Specialization
Citations

This map shows the geographic impact of Т. И. Романцова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Т. И. Романцова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Т. И. Романцова more than expected).

Fields of papers citing papers by Т. И. Романцова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Т. И. Романцова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Т. И. Романцова. The network helps show where Т. И. Романцова may publish in the future.

Co-authorship network of co-authors of Т. И. Романцова

This figure shows the co-authorship network connecting the top 25 collaborators of Т. И. Романцова. A scholar is included among the top collaborators of Т. И. Романцова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Т. И. Романцова. Т. И. Романцова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Трошина, Е. А., М. Б. Анциферов, Ametov As, et al.. (2025). A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide. Problems of Endocrinology. 71(5). 19–30.
2.
Романцова, Т. И.. (2025). Tirzepatide: unimolecular polypharmacology in the treatment of obesity. 14(3). 50–64. 1 indexed citations
3.
Романцова, Т. И.. (2024). Innovative approaches to the treatment of obesity: from pharmacotherapy to nanomedicine. SHILAP Revista de lepidopterología. 21(4). 389–404.
4.
Дедов, И. И., G. А. Melnichenko, Larisa Dzeranova, et al.. (2023). Clinical guidelines ‘Hyperprolactinemia’ (draft). SHILAP Revista de lepidopterología. 20(2). 170–188. 1 indexed citations
5.
Романцова, Т. И., et al.. (2021). The importance of melatonin in the regulation of metabolism, eating behavior, sleep, and the prospects for the use of melatonin drugs for obesity treatment. SHILAP Revista de lepidopterología. 18(2). 112–124. 8 indexed citations
6.
Романцова, Т. И., et al.. (2020). Metabolically healthy obesity: prevalence, phenotype characteristic, effectiveness of weight loss. SHILAP Revista de lepidopterología. 9(3). 1 indexed citations
7.
Романцова, Т. И., et al.. (2019). The influence of shift work on metabolic health. SHILAP Revista de lepidopterología. 16(3). 11–19. 6 indexed citations
8.
Дедов, И. И., Т. И. Романцова, & Marina V. Shestakova. (2019). Rational approach to patients treatment with type 2 diabetes and obesity: results of the All-Russian observational program «AURORA». SHILAP Revista de lepidopterología. 15(4). 48–58. 7 indexed citations
9.
Tanashyan, M. М., et al.. (2019). Poststroke recovery in patients with type 2 diabetes mellitus. Фарматека. 3_2019. 65–70. 1 indexed citations
10.
Романцова, Т. И.. (2018). Gglucagon-like peptide-1 analogue liraglutide (Saxenda®): mechanism of action, efficacy for the treatment of obesity. Obesity and metabolism. 15(1). 3–11. 9 indexed citations
11.
Романцова, Т. И., et al.. (2017). The prevalence of metabolically healthy obesity according to the sample of the Moscow region. Obesity and metabolism. 14(4). 51–56. 5 indexed citations
12.
Романцова, Т. И., et al.. (2015). Метаболически здоровое ожирение: дефиниции, протективные факторы, клиническая значимость. SHILAP Revista de lepidopterología. 1(1). 75–86. 10 indexed citations
13.
Романцова, Т. И.. (2015). Metabolically healthy obese: definitions, protective factors, clinical significance. 6 indexed citations
14.
Романцова, Т. И., et al.. (2014). Комплексный подход в лечении метаболического синдрома.
15.
Kalashnikova, Marina, et al.. (2014). Clinical and economic analysis of the modern strategies for treating metabolic syndrome. Diabetes Mellitus. 17(2). 116–125.
16.
Сереженков, В. А., et al.. (2013). Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor. SHILAP Revista de lepidopterología. 16(3). 116–116. 1 indexed citations
17.
Романцова, Т. И., et al.. (2013). Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment. SHILAP Revista de lepidopterología. 16(1). 48–51. 1 indexed citations
18.
Сереженков, В. А., et al.. (2013). Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor. SHILAP Revista de lepidopterología. 41–45. 2 indexed citations
19.
Романцова, Т. И., et al.. (2010). Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride. Diabetes Mellitus. 13(1). 50–54. 2 indexed citations
20.
Melnichenko, G. А., et al.. (2002). Results of long observation of patients with moderate hyperprolactinemia. Problems of Endocrinology. 48(3). 18–22.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026